Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Mintzes

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Drug and Therapeutics Bulletin|November 28, 2024
Does menopause hormone therapy prevent Alzheimer's disease and dementia?Barbara Mintzes, Adriane Fugh-Berman
Obstetrics and Gynecology|July 26, 2016
In ReplyGillian E Hanley, Barbara Mintzes
The Medical Journal of Australia|June 9, 2012
Disease mongering and low testosterone in men: the tale of two regulatory failuresAgnes I Vitry, Barbara Mintzes
American Family Physician|July 30, 2025
Menopausal Hormone Therapy: Limited Benefits, Significant HarmsAdriane Fugh-Berman, Barbara Mintzes
The Medical Journal of Australia|April 16, 2024
Pharmaceutical company payments to Australian doctors reported to Medicines Australia, 2019-22: a cross-sectional analysisMalcolm Forbes, Yeshna Bhowon, Barbara Mintzes
Health Affairs (Project Hope)|May 27, 2004
Outcomes-based drug coverage in British ColumbiaSteven Morgan, Ken Bassett, Barbara Mintzes
Health Promotion International|May 30, 2026
The illusion of empowerment: commercializing women's health in the digital ageBrooke Nickel, Tessa Copp, Barbara Mintzes
Drug and Therapeutics Bulletin|October 13, 2021
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedentBarbara Mintzes, Leonore Tiefer, Lisa Cosgrove
Pharmacoeconomics|June 20, 2008
Does direct-to-consumer advertising of antidepressants lead to a net social benefit?Jon Jureidini, Barbara Mintzes, Melissa Raven
Australian Health Review : a Publication of the Australian Hospital Association|July 20, 2018
How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional studyEdith Lau, Alice Fabbri, Barbara Mintzes
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Drug and Therapeutics Bulletin|November 28, 2024
Does menopause hormone therapy prevent Alzheimer's disease and dementia?Barbara Mintzes, Adriane Fugh-Berman
Obstetrics and Gynecology|July 26, 2016
In ReplyGillian E Hanley, Barbara Mintzes
The Medical Journal of Australia|June 9, 2012
Disease mongering and low testosterone in men: the tale of two regulatory failuresAgnes I Vitry, Barbara Mintzes
American Family Physician|July 30, 2025
Menopausal Hormone Therapy: Limited Benefits, Significant HarmsAdriane Fugh-Berman, Barbara Mintzes
The Medical Journal of Australia|April 16, 2024
Pharmaceutical company payments to Australian doctors reported to Medicines Australia, 2019-22: a cross-sectional analysisMalcolm Forbes, Yeshna Bhowon, Barbara Mintzes
Health Affairs (Project Hope)|May 27, 2004
Outcomes-based drug coverage in British ColumbiaSteven Morgan, Ken Bassett, Barbara Mintzes
Health Promotion International|May 30, 2026
The illusion of empowerment: commercializing women's health in the digital ageBrooke Nickel, Tessa Copp, Barbara Mintzes
Drug and Therapeutics Bulletin|October 13, 2021
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedentBarbara Mintzes, Leonore Tiefer, Lisa Cosgrove
Pharmacoeconomics|June 20, 2008
Does direct-to-consumer advertising of antidepressants lead to a net social benefit?Jon Jureidini, Barbara Mintzes, Melissa Raven
Australian Health Review : a Publication of the Australian Hospital Association|July 20, 2018
How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional studyEdith Lau, Alice Fabbri, Barbara Mintzes
Pageof 17